黄志瑾:法学博士,复旦大学博士后流动站,上海对外经贸大学国际经贸研究所副研究员。研究方向:国际投资法。
D996
本文受教育部人文社会科学研究青年项目“《跨太平洋伙伴关系协定》国有企业规则研究”(项目编号:16YJC820012)和国家社科基金青年项目“中国引领投资便利化国际合作的法律研究”(项目编号:18CFX086)的资助,同时受上海对外经贸大学中东欧研究中心资助。
“条约救济风险”是指投资争议发生以后,投资者通过BIT、FTA或其他条约中的“投资者—东道国争端解决条款”以及其他实体性条款,向一个中立的、不隶属于任何国家的机构寻求救济的可能性。中东欧16国均为“一带一路”倡议沿线国,中国—中东欧国家的投资条约救济情况在“一带一路”沿线具有代表性,对中东欧16国的实证研究将有助于对“一带一路”沿线国家的投资条约救济风险的深度理解和对该区域更为扎实的评估。中国企业在中东欧16国的投资普遍具有中度风险,匈牙利是需要特别关注的国家、黑山是风险最高的国家、捷克是我国未来修订BIT需重点参考的国家。
“Treaty Remedy Risk” refers to the possibility of investors seeking remedies through a “investor-state dispute settlement clause” in BIT, FTA, or other treaties after an investment dispute occurs, to a neutral institution that is not affiliated with any country. Sixteen CEE countries are countries along the “B & R” initiative. The remedy of investment treaties between China and Central and Eastern Europe is representative along the “B & R”, and the empirical study of 16 countries in Central and Eastern Europe will be helpful to the “B & R Initiative”. This article tries to deeply understand the risk remedies from investment treaties in countries along the route and make a more solid assessment of the region. Chinese companies generally have moderate risks in investing in CEE countries. Hungary is a country that needs special attention, Montenegro is the country with the highest risk, and the Czech Republic is the country to which the country’s future revision of BIT must focus on.
黄志瑾,张万洪.“一带一路”投资中的条约救济风险——基于中东欧国家的实证研究[J].上海对外经贸大学学报,2018,(4):39-47.
复制